Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Value Concentration
View:
Post by TheMadMonk on Feb 26, 2022 12:46pm

Value Concentration

444,925 warrants expire tomorrow February 27th worthless, thus concentrating value for existing shareholders by approximately 0.85%.  Next lot of nearly 2.9 million warrants is set to expire June 30th 2022, and then another lot in the middle of August.  In total once all the 2022 warrants expire it will increase existing shareholder equity by approximately 7.8%.  With some news hopefully starting to flow by mid-year, 2022 looks to be exciting for ATE shareholders.
Comment by MrMugsy on Feb 27, 2022 12:48pm
Well said MadMonk. Will take as many expired warrants as we can get. Cheers !
Comment by StockingUp21 on Feb 27, 2022 1:03pm
One nice way to look at total failing and very bad for raisinf money next time a round
Comment by MrMugsy on Feb 27, 2022 1:09pm
Let's worry about money if we ever need to go in search of it again.   Right now, let's get 346 and 352 to P2.  By then we'll also know where we stand on the chronic side and what's needed next. Also remember, summer is a world away when it comes to drug development companies - too early to tell where we'll be by then. Good Luck Longs !!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities